Viridian Therapeutics Inc. is a biotechnology company advancing new treatments for patients suffering from serious diseases. The company's program includes VRDN-001, which is in clinical stage. Viridian Therapeutics Inc., formerly known as miRagen Therapeutics Inc., is based in BOULDER, Colo.
Info & Links
CEO
Stephen Mahoney
Headquarters
221 CRESCENT STREET, SUITE 103A WALTHAM, MA 02453, UNITED STATES
Viridian Therapeutics, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
1.07B
Enterprise Value
990.89M
Enterprise Value/EBITDA(ttm)
-3.15
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
4.36K
Price to Book(mrq)
2.05
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
100.00%
Operating Margin(ttm)
-85127.16%
Profit Margin(ttm)
-89397.49%
Return on Equity(ttm)
-70.12%
Return on Invested Capital(ttm)
-41.99%
Return on Assets(ttm)
-41.49%
Income Statement
Revenue(ttm)
302.00K
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
302.00K
EBITDA(ttm)3
-314.15M
Net Income Available to Common(ttm)
-269.95M
Diluted EPS(ttm)
-4.31
Share Statistics
Beta (5Y Monthly)
1.32
52-Week Change
-13.40%
S&P 500 52-Week Change
5.43%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
81.48M
Dividend Yield
0.00%
Float4
78.70M
% Held by Insiders
0.65%
% Held by Institutions
--
Balance Sheet
Total Cash(mrq)
717.58M
Total Cash Per Share(mrq)
8.81
Total Debt(mrq)
20.58M
Total Debt/Equity(mrq)
3.06%
Current Ratio(mrq)
15.43%
Quick Ratio(mrq)
18.55%
Book Value Per Share(mrq)
8.29
Cash Flow
Operating Cash Flow Per Share(ytd)
-3.42
Free Cash Flow(ytd)
-232.83M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.